Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06773377
Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
1. Study the expression of CD44 in various histopathological types of RCC. 2. Study the association between CD44 expression and other clinicopathological parameters 3. study the impact of CD44 expressions in tumor and patients' survival
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
77
Start Date
2025-11-01
Completion Date
2026-12-01
Last Updated
2025-01-14
Healthy Volunteers
No